Lamictal 50 mg chewable/dispersible tablets

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Nopērc to tagad

Lietošanas instrukcija Lietošanas instrukcija (PIL)
29-08-2020
Produkta apraksts Produkta apraksts (SPC)
01-06-2017

Aktīvā sastāvdaļa:

Lamotrigine

Pieejams no:

Lexon (UK) Ltd

ATĶ kods:

N03AX; N03AX09

SNN (starptautisko nepatentēto nosaukumu):

Lamotrigine

Deva:

50 milligram(s)

Zāļu forma:

Chewable/dispersible tablet

Receptes veids:

Product subject to prescription which may be renewed (B)

Ārstniecības joma:

Other antiepileptics; lamotrigine

Autorizācija statuss:

Authorised

Autorizācija datums:

2017-05-19

Lietošanas instrukcija

                                READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
*
Keep this leaflet. You may need to read it again.
*
If you have any further questions, ask your doctor or pharmacist.
*
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.
*
If you get any of the side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this leaflet.
See
section 4.
WHAT IS IN THIS LEAFLET
What Lamictal is and what it is used for
What you need to know before you take Lamictal
How to take Lamictal
Possible side effects
How to store Lamictal
Contents of the pack and other information
WHAT LAMICTAL IS AND WHAT IT IS USED FOR
Lamictal belongs to a group of medicines called _anti-epileptics_. It
is used to
treat two conditions — EPILEPSY and BIPOLAR DISORDER.
LAMICTAL TREATS EPILEPSY by blocking the signals in the brain that
trigger
epileptic seizures (fits).
• For adults and children aged 13 years and over, Lamictal can be
used on
its own or with other medicines, to treat epilepsy. Lamictal can also
be used
with other medicines to treat the seizures that occur with a condition
called
Lennox-Gastaut syndrome.
• For children aged between 2 and 12 years, Lamictal can be used
with other
medicines, to treat those conditions. It can be used on its own to
treat a
type of epilepsy called typical absence seizures.
LAMICTAL ALSO TREATS BIPOLAR DISORDER.
People with bipolar disorder (sometimes called _manic depression_)
have
extreme mood swings, with periods of mania (excitement or euphoria)
alternating with periods of depression (deep sadness or despair). For
adults aged 18 years and over, Lamictal can be used on its own or with
other
medicines, to prevent the periods of depression that occur in bipolar
disorder.
It is not yet known how Lamictal works in the brain to have this
effect.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE LAMICTAL
DO NOT TAKE
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Lamictal 50 mg chewable/dispersible tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Lamictal 50 mg chewable/dispersible tablet contains 50 mg
lamotrigine.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Chewable/dispersible tablet.
_Product imported from Germany_
White to off-white multi-faceted, super-elliptical, tablets with a
blackcurrant odour, marked "GSCX7" on one side and
"50" on the other. The tablets may be slightly mottled.
4 CLINICAL PARTICULARS
As per PA1077/061/008
5 PHARMACOLOGICAL PROPERTIES
As per PA1077/061/008
6 PHARMACEUTICAL PARTICULARS
6.1 LIST OF EXCIPIENTS
Calcium carbonate
Hyprolose
Aluminium magnesium silicate
Poly(O-carboxymethyl) starch, sodium salt
Povidone K30
Sodium saccharine
Magnesium stearate (Ph. Eur.)
Blackcurrant flavour
6.2 INCOMPATIBILITIES
Not applicable.
6.3 SHELF LIFE
The shelf life expiry date for this product shall be the date shown on
the blister and outer package of the product on the
market in the country of origin.
6.4 SPECIAL PRECAUTIONS FOR STORAGE
This medicinal product does not require any special storage
conditions.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_0_
_/_
_0_
_5_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_2_
_1_
_9_
_3_
_2_
_1_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
6.5 NATURE AND CONTENTS OF CONTAINER
Blister packs of 56 tablets.
6.6 SPECIAL PRECAUTIONS FOR DISPOSAL
No special requirements.
7 PARAL
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu